KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Esperion Therapeutics (ESPR) over the last 6 years, with Q3 2025 value amounting to $55.0 million.

  • Esperion Therapeutics' Treasury Shares changed 0.0% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $55.0 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Esperion Therapeutics' Treasury Shares is $2.0 million, which was down 0.0% from $2.0 million recorded in Q2 2025.
  • Esperion Therapeutics' 5-year Treasury Shares high stood at $2.0 million for Q1 2021, and its period low was $2.0 million during Q1 2021.
  • Over the past 5 years, Esperion Therapeutics' median Treasury Shares value was $2.0 million (recorded in 2021), while the average stood at $2.0 million.
  • Over the last 5 years, Esperion Therapeutics' Treasury Shares had its largest YoY gain of 0.0% in 2021, and its largest YoY loss of 0.0% in 2021.
  • Over the past 5 years, Esperion Therapeutics' Treasury Shares (Quarter) stood at $55.0 million in 2021, then changed by 0.0% to $55.0 million in 2022, then changed by 0.0% to $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
  • Its Treasury Shares was $55.0 million in Q3 2025, compared to $55.0 million in Q2 2025 and $55.0 million in Q1 2025.